Skip to main content
. 2021 Sep 25;12(11):2891–2905. doi: 10.1007/s13300-021-01141-8

Fig. 1.

Fig. 1

Patient disposition. aPatients who initiated semaglutide treatment and attended the EOS visit; b37 (21.6%) visits were carried out by telephone due to restrictions related to the coronavirus pandemic and 34 (19.9%) EOS visits were performed outside of the 28- to 38-week visit window. EAS effective analysis set, EOS end of study, FAS full analysis set, GI gastrointestinal